The authors reported that visfatin upregulates VEGF-C expression by activating the MEK1/2-ERK and NF-κB signaling pathways, leading to increased lymphovascular invasion and contributing to ESCC progression and metastasis [44]. This evidence concerns the gene NAMPT and esophageal squamous cell carcinoma.